NPP-4 is our skin pigmentation project. We plan to launch a self-tanning product based on NPP-4 in 2026, in collaboration with one or more partners.
NPP-4 works by stimulating the transport of melanin to the outermost layer of the skin, mimicking the natural process that occurs during sun exposure or tanning beds, but without the risks associated with UV radiation.
The market for self-tanning products is huge and steadily growing, driven by the high demand for new, safe solutions to achieve a tan without sun exposure. Most self-tanning products on the market today often contain the ingredient dihydroxyacetone (DHA). DHA can increase the production of free radicals in the skin, leading to premature aging and damage to collagen and elastin.
Global sales today are estimated at more than USD 1 billion, and by 2032, sales are projected to reach nearly USD 2 billion.
Market value
2025
License agreement with commercial partners
2025
Cosmetic tests carried out and necessary permits obtained in key markets
2026
Production upscale finalized
2026
Product launch in key markets
NPP-4 works by stimulating the transport of melanin to the outermost layer of the skin, mimicking the natural process that occurs during sun exposure or tanning beds, but without the risks associated with UV radiation.
This peptide has been developed through a research collaboration with the University of Bradford. It is one of four pigmentation peptides.